CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
control and the preferred method of attachment of the CivaSheet in the setting of suspected close or positive margins at the time of surgical tumor...
Phase 1, Phase 2
Chicago, Illinois, United States and 4 other locations
Subjects will be offered the opportunity to participate in a randomized, controlled, 2-arm, unblinded multicenter trial (RCT). There will be 2 study...
Phase 3
Arlington Heights, Illinois, United States and 5 other locations
A) vs. mFOLFIRINOX plus placebo (Arm B) in 94 subjects with advanced pancreatic cancer, not amenable to curative treatment. Both ar...
Phase 2
Munster, Indiana, United States and 7 other locations
Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...
Phase 2
Chicago, Illinois, United States and 135 other locations
A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS muta...
Phase 1
Chicago, Illinois, United States and 22 other locations
in combination with gemcitabine and nab-paclitaxel in patients with Pancreatic Ductal Adenocarcinoma (PDAC) who have been previously untreat...
Phase 1, Phase 2
Chicago, Illinois, United States and 11 other locations
phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety pr...
Phase 1
Chicago, Illinois, United States and 55 other locations
compared to just chemotherapy alone in participants with metastatic pancreatic cancer. One group of participants will only receive ...
Phase 2
Arlington Heights, Illinois, United States and 35 other locations
A Phase Ib/II, open-label, multicenter, randomized study designed to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumor...
Phase 1, Phase 2
Chicago, Illinois, United States and 26 other locations
to participants. Part C will use the information from Parts A and B to see if PF-08046049/SGN-BB228 is safe and if it works to treat solid tumor...
Phase 1
Chicago, Illinois, United States and 21 other locations
Clinical trials
Research sites
Resources
Legal